DK3536807T3 - Noninvasive determination of fetal or tumor methyloma from plasma - Google Patents

Noninvasive determination of fetal or tumor methyloma from plasma Download PDF

Info

Publication number
DK3536807T3
DK3536807T3 DK19171630.7T DK19171630T DK3536807T3 DK 3536807 T3 DK3536807 T3 DK 3536807T3 DK 19171630 T DK19171630 T DK 19171630T DK 3536807 T3 DK3536807 T3 DK 3536807T3
Authority
DK
Denmark
Prior art keywords
methyloma
fetal
tumor
plasma
noninvasive determination
Prior art date
Application number
DK19171630.7T
Other languages
Danish (da)
Inventor
Rossa Wai Kwun Chiu
Kwan Chee Chan
Yuk-Ming Dennis Lo
Miu Fan Lun
Peiyong Jiang
Wai Man Chan
Original Assignee
Univ Hong Kong Chinese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50340462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3536807(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US13/842,209 external-priority patent/US9732390B2/en
Application filed by Univ Hong Kong Chinese filed Critical Univ Hong Kong Chinese
Application granted granted Critical
Publication of DK3536807T3 publication Critical patent/DK3536807T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK19171630.7T 2012-09-20 2013-09-20 Noninvasive determination of fetal or tumor methyloma from plasma DK3536807T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261703512P 2012-09-20 2012-09-20
US13/842,209 US9732390B2 (en) 2012-09-20 2013-03-15 Non-invasive determination of methylome of fetus or tumor from plasma
US201361830571P 2013-06-03 2013-06-03
EP17202149.5A EP3354747B1 (en) 2012-09-20 2013-09-20 Non-invasive determination of methylome of tumor from plasma

Publications (1)

Publication Number Publication Date
DK3536807T3 true DK3536807T3 (en) 2024-02-05

Family

ID=50340462

Family Applications (3)

Application Number Title Priority Date Filing Date
DK17202149.5T DK3354747T3 (en) 2012-09-20 2013-09-20 Non-invasive determination of tumor methyloma from plasma
DK13838770.9T DK2898100T4 (en) 2012-09-20 2013-09-20 Non-invasive determination of a fetal methyloma or tumor from plasma
DK19171630.7T DK3536807T3 (en) 2012-09-20 2013-09-20 Noninvasive determination of fetal or tumor methyloma from plasma

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK17202149.5T DK3354747T3 (en) 2012-09-20 2013-09-20 Non-invasive determination of tumor methyloma from plasma
DK13838770.9T DK2898100T4 (en) 2012-09-20 2013-09-20 Non-invasive determination of a fetal methyloma or tumor from plasma

Country Status (27)

Country Link
EP (6) EP3839065A1 (en)
JP (5) JP6317354B2 (en)
KR (5) KR102390711B1 (en)
CN (2) CN117757932A (en)
AU (4) AU2013317708C1 (en)
BR (3) BR112015006183B1 (en)
CA (2) CA3122779A1 (en)
CY (1) CY1124139T1 (en)
DK (3) DK3354747T3 (en)
EA (1) EA201500327A1 (en)
ES (3) ES2969567T3 (en)
FI (1) FI3536807T3 (en)
HK (3) HK1206797A1 (en)
HR (2) HRP20240210T1 (en)
HU (1) HUE053822T2 (en)
IL (3) IL299444A (en)
LT (1) LT3354747T (en)
MX (1) MX360034B (en)
MY (2) MY173356A (en)
NZ (2) NZ706269A (en)
PH (1) PH12015500547A1 (en)
PL (3) PL3354747T3 (en)
PT (3) PT3536807T (en)
SG (2) SG11201501927VA (en)
TW (5) TWI640634B (en)
WO (1) WO2014043763A1 (en)
ZA (1) ZA201501772B (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101153336B (en) 2006-09-27 2011-09-07 香港中文大学 Diagnostic method for detecting DNA methylation degree
US9892230B2 (en) 2012-03-08 2018-02-13 The Chinese University Of Hong Kong Size-based analysis of fetal or tumor DNA fraction in plasma
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
EP3839065A1 (en) 2012-09-20 2021-06-23 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
EP3029148B1 (en) * 2013-07-30 2018-06-27 BGI Genomics Co., Limited Method for determining nucleic acid composition of nucleic acid mixture
US10174375B2 (en) 2013-09-20 2019-01-08 The Chinese University Of Hong Kong Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases
CN106029909B (en) * 2014-02-18 2021-02-02 生物纳米基因公司 Improved method for determining nucleic acid structural information
EP2942400A1 (en) 2014-05-09 2015-11-11 Lifecodexx AG Multiplex detection of DNA that originates from a specific cell-type
JP6681841B2 (en) 2014-05-09 2020-04-15 ライフコーデックス アーゲー Detection of DNA from special cell types and related methods
WO2016010401A1 (en) * 2014-07-18 2016-01-21 에스케이텔레콘 주식회사 Method for expecting fetal single nucleotide polymorphisms using maternal serum dna
EP3889272A1 (en) * 2014-07-18 2021-10-06 The Chinese University of Hong Kong Methylation pattern analysis of tissues in dna mixture
WO2016015058A2 (en) 2014-07-25 2016-01-28 University Of Washington Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
US10364467B2 (en) * 2015-01-13 2019-07-30 The Chinese University Of Hong Kong Using size and number aberrations in plasma DNA for detecting cancer
CN107771221B (en) * 2015-02-10 2021-11-02 香港中文大学 Mutation detection for cancer screening and fetal analysis
HUE059407T2 (en) 2015-07-20 2022-11-28 Univ Hong Kong Chinese Methylation pattern analysis of haplotypes in tissues in dna mixture
HUE064231T2 (en) * 2015-07-23 2024-02-28 Univ Hong Kong Chinese Analysis of fragmentation patterns of cell-free dna
US11319586B2 (en) 2015-08-12 2022-05-03 The Chinese University Of Hong Kong Single-molecule sequencing of plasma DNA
CN115035949A (en) 2015-09-22 2022-09-09 香港中文大学 Accurate quantification of fetal DNA fraction by shallow depth sequencing of maternal plasma DNA
US10260088B2 (en) * 2015-10-30 2019-04-16 New England Biolabs, Inc. Compositions and methods for analyzing modified nucleotides
WO2017083366A1 (en) * 2015-11-09 2017-05-18 Progenity, Inc. Methods for determining the origin of dna molecules
EP3168309B8 (en) 2015-11-10 2020-06-03 Eurofins LifeCodexx GmbH Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female
AU2016370835B2 (en) * 2015-12-17 2020-02-13 Illumina, Inc. Distinguishing methylation levels in complex biological samples
CN116640847A (en) * 2016-02-02 2023-08-25 夸登特健康公司 Cancer evolution detection and diagnosis
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
CA3022606A1 (en) * 2016-05-03 2017-11-09 University Health Network Methods of capturing cell-free methylated dna and uses of same
US20190256921A1 (en) * 2016-05-04 2019-08-22 Queen's University At Kingston Cell-free detection of methylated tumour dna
CA3025708A1 (en) * 2016-05-30 2017-12-07 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free dna in blood
WO2017218908A2 (en) * 2016-06-16 2017-12-21 The Johns Hopkins University Methods and system for epigenetic analysis
WO2018036537A1 (en) * 2016-08-24 2018-03-01 中国科学院上海生命科学研究院 Novel modification of 5-methylcytosine catalyzed by cmd1 enzyme and application thereof
US11512306B2 (en) 2016-10-19 2022-11-29 The Chinese University Of Hong Kong Gestational age assessment by methylation and size profiling of maternal plasma DNA
WO2018081130A1 (en) 2016-10-24 2018-05-03 The Chinese University Of Hong Kong Methods and systems for tumor detection
EP3548632A4 (en) 2016-11-30 2020-06-24 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
US20190309374A1 (en) * 2016-12-13 2019-10-10 Bellwether Bio, Inc. Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample
BR112019014208A2 (en) * 2017-01-11 2020-03-17 Quest Diagnostics Investments Llc METHODS TO DETECT FALSE-POSITIVE DIAGNOSIS OF CHROMOSOMIC ANEUPLOIDIA IN A FETUS AND TO DETECT FALSE-POSITIVE ANEUPLOIDIAGNOSTIC ANEUPLOIDIA DIAGNOSIS IN A FETUS.
EP3575407B1 (en) * 2017-01-24 2024-03-27 BGI Genomics Co., Ltd. Method for determining proportion of cell-free nucleic acids from predetermined source in biological sample
TW202348802A (en) 2017-01-25 2023-12-16 香港中文大學 Diagnostic applications using nucleic acid fragments
CN107247873B (en) * 2017-03-29 2020-04-14 电子科技大学 Differential methylation site recognition method
US20200109456A1 (en) * 2017-05-12 2020-04-09 President And Fellows Of Harvard College Universal early cancer diagnostics
KR102628878B1 (en) * 2017-07-12 2024-01-23 유니버시티 헬스 네트워크 Cancer detection and classification using methylome analysis
EP3658684B1 (en) 2017-07-26 2023-08-30 The Chinese University Of Hong Kong Enhancement of cancer screening using cell-free viral nucleic acids
US20200263170A1 (en) 2017-09-14 2020-08-20 Grail, Inc. Methods for preparing a sequencing library from single-stranded dna
US11851650B2 (en) 2017-09-28 2023-12-26 Grail, Llc Enrichment of short nucleic acid fragments in sequencing library preparation
US11168356B2 (en) 2017-11-02 2021-11-09 The Chinese University Of Hong Kong Using nucleic acid size range for noninvasive cancer detection
US11884966B2 (en) * 2018-03-15 2024-01-30 Grail, Llc Tissue-specific methylation marker
AU2019253118B2 (en) * 2018-04-13 2024-02-22 Freenome Holdings, Inc. Machine learning implementation for multi-analyte assay of biological samples
US11932899B2 (en) * 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
CN109448789A (en) * 2018-09-17 2019-03-08 上海派森诺生物科技股份有限公司 A kind of automated analysis method of the special SNP site of population based on perl language
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC Methylation markers and targeted methylation probe panel
CN109295230A (en) * 2018-10-24 2019-02-01 福建翊善生物科技有限公司 A method of the polygene combined abrupt climatic change based on ctDNA assesses tumour dynamic change
WO2020125709A1 (en) * 2018-12-19 2020-06-25 The Chinese University Of Hong Kong Cell-free dna end characteristics
EP3899953A1 (en) 2018-12-21 2021-10-27 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
WO2020163410A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
WO2020163403A1 (en) 2019-02-05 2020-08-13 Grail, Inc. Detecting cancer, cancer tissue of origin, and/or a cancer cell type
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
WO2020227100A1 (en) * 2019-05-03 2020-11-12 Cornell University Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes
KR102452413B1 (en) * 2019-08-19 2022-10-11 주식회사 지씨지놈 Method for detecting chromosomal abnormality using distance information between nucleic acid fragments
JP2022544626A (en) * 2019-08-19 2022-10-19 グリーン クロス ゲノム コーポレーション Chromosomal aberration detection method using distance information between nucleic acid fragments
GB201915469D0 (en) 2019-10-24 2019-12-11 Univ London Cancer detection methods
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
EP4111457A1 (en) * 2020-02-28 2023-01-04 Grail, LLC Identifying methylation patterns that discriminate or indicate a cancer condition
CN112662764A (en) * 2020-03-17 2021-04-16 博尔诚（北京）科技有限公司 Probe composition for detecting 11 cancers
RU2738675C1 (en) * 2020-07-28 2020-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Method for prediction of the risk of developing preeclampsia in women without an aggravated family history taking into account genetic factors
CN112813148A (en) * 2021-02-02 2021-05-18 博淼生物科技（北京）有限公司 Method for detecting 5-hydroxymethylcytosine by flight time mass spectrum
WO2023052917A1 (en) * 2021-09-28 2023-04-06 Act Genomics (ip) Limited Methylation biomarker selection apparatuses and methods
KR20230059423A (en) * 2021-10-26 2023-05-03 주식회사 지씨지놈 Method for diagnosing and predicting cancer type using methylated cell free DNA
WO2023079047A1 (en) * 2021-11-04 2023-05-11 Universal Diagnostics S.A Systems and methods for preparing biological samples for genetic sequencing
CN115064211B (en) * 2022-08-15 2023-01-24 臻和(北京)生物科技有限公司 ctDNA prediction method and device based on whole genome methylation sequencing
CN115612723B (en) * 2022-09-26 2023-07-14 广州女娲生命科技有限公司 Screening method of embryo before implantation
CN117025753A (en) * 2023-08-15 2023-11-10 广州女娲生命科技有限公司 Method and device for detecting chromosomal variation
CN117079822B (en) * 2023-10-17 2024-01-02 北京大学第三医院（北京大学第三临床医学院） System for predicting fetal brain injury by four factors in early and middle gestation period

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927028B2 (en) * 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
ES2253461T3 (en) † 2002-03-05 2006-06-01 Epigenomics Ag PROCEDURE AND DEVICE FOR THE DETERMINATION OF THE SPECIFICITY OF THE TISSUE AND OF THE DNA THAT FLEETS FREE IN BODY FABRICS.
AU2003294315A1 (en) * 2002-11-19 2004-06-15 Amgen Inc. Amplified genes involved in cancer
US20060183128A1 (en) † 2003-08-12 2006-08-17 Epigenomics Ag Methods and compositions for differentiating tissues for cell types using epigenetic markers
DE10348407A1 (en) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostic and diagnostic markers for cell proliferative disorders of breast tissues
EP2290106B1 (en) * 2004-03-08 2018-01-03 Rubicon Genomics, Inc. Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
AU2006251937A1 (en) 2005-05-27 2006-11-30 John Wayne Cancer Institute Use of free circulating DNA for diagnosis, prognosis, and treatment of cancer
US7754428B2 (en) * 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
US7901884B2 (en) * 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
CN101153336B (en) * 2006-09-27 2011-09-07 香港中文大学 Diagnostic method for detecting DNA methylation degree
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
KR20160113145A (en) 2007-07-23 2016-09-28 더 차이니즈 유니버시티 오브 홍콩 Determining a nucleic acid sequence imbalance
US20110028333A1 (en) 2009-05-01 2011-02-03 Brown University Diagnosing, prognosing, and early detection of cancers by dna methylation profiling
US8563242B2 (en) * 2009-08-11 2013-10-22 The Chinese University Of Hong Kong Method for detecting chromosomal aneuploidy
US20120208711A1 (en) 2009-10-02 2012-08-16 Centre For Addiction And Mental Health Method for Analysis of DNA Methylation Profiles of Cell-Free Circulating DNA in Bodily Fluids
PL3241914T3 (en) * 2009-11-05 2019-08-30 The Chinese University Of Hong Kong Fetal genomic analysis from a maternal biological sample
MX357692B (en) 2009-11-06 2018-07-19 Univ Hong Kong Chinese Size-based genomic analysis.
CA2786564A1 (en) * 2010-01-19 2011-07-28 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
WO2011092592A2 (en) † 2010-01-26 2011-08-04 Nipd Genetics Ltd Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
CA3007805C (en) † 2010-04-29 2019-11-26 The Regents Of The University Of California Pathway recognition algorithm using data integration on genomic models (paradigm)
GB201007944D0 (en) * 2010-05-12 2010-06-30 Univ Aberystwyth Methods
US10167513B2 (en) 2010-05-25 2019-01-01 The Johns Hopkins University Compositions and methods for detecting a neoplasia
EP4303584A3 (en) * 2010-07-23 2024-04-03 President and Fellows of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
JP2013530727A (en) * 2010-07-23 2013-08-01 エソテリックス ジェネティック ラボラトリーズ， エルエルシー Identification and use of differentially presented fetal or maternal genomic regions
WO2012031329A1 (en) 2010-09-10 2012-03-15 Murdoch Childrens Research Institute Assay for detection and monitoring of cancer
TWI719339B (en) † 2010-11-30 2021-02-21 香港中文大學 Detection of genetic or molecular aberrations associated with cancer
EP3839065A1 (en) 2012-09-20 2021-06-23 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma

Also Published As

Publication number Publication date
HK1257868A1 (en) 2019-11-01
AU2022201026A1 (en) 2022-03-10
MX360034B (en) 2018-10-19
PL3354747T3 (en) 2021-07-26
EP2898100A1 (en) 2015-07-29
EP3354747B1 (en) 2021-02-17
JP6683752B2 (en) 2020-04-22
ZA201501772B (en) 2016-10-26
PH12015500547A1 (en) 2015-05-04
EP3839065A1 (en) 2021-06-23
TWI640634B (en) 2018-11-11
JP2022031753A (en) 2022-02-22
PT3536807T (en) 2024-02-01
HK1206797A1 (en) 2016-01-15
LT3354747T (en) 2021-04-12
NZ706269A (en) 2016-08-26
BR122021021825B1 (en) 2022-05-24
DK2898100T4 (en) 2023-07-24
AU2020200128A1 (en) 2020-01-30
FI3536807T3 (en) 2024-02-01
BR122021021823B1 (en) 2023-04-25
SG10201705198UA (en) 2017-07-28
KR102148547B1 (en) 2020-08-26
EP2898100B1 (en) 2017-11-22
TW202043483A (en) 2020-12-01
CN117757932A (en) 2024-03-26
JP2020108400A (en) 2020-07-16
AU2020200128B2 (en) 2021-11-18
EP4335929A3 (en) 2024-05-29
ES2665273T5 (en) 2023-10-02
PT2898100T (en) 2018-02-26
CN104781422A (en) 2015-07-15
PL3536807T3 (en) 2024-05-06
CY1124139T1 (en) 2022-05-27
DK2898100T3 (en) 2018-02-26
KR20200085928A (en) 2020-07-15
KR20210120124A (en) 2021-10-06
IL268512B2 (en) 2023-06-01
MX2015003571A (en) 2015-06-22
AU2017251832B2 (en) 2019-10-10
TW202305145A (en) 2023-02-01
TWI784258B (en) 2022-11-21
EP4335929A2 (en) 2024-03-13
AU2013317708C1 (en) 2017-11-23
AU2013317708A1 (en) 2015-04-09
ES2862726T3 (en) 2021-10-07
KR20150082228A (en) 2015-07-15
IL268512A (en) 2019-09-26
JP2024009833A (en) 2024-01-23
BR112015006183B1 (en) 2022-04-26
ES2969567T3 (en) 2024-05-21
TW201418474A (en) 2014-05-16
KR102390711B1 (en) 2022-04-26
CA2884066C (en) 2021-08-10
NZ717423A (en) 2017-08-25
PL2898100T3 (en) 2018-06-29
ES2665273T3 (en) 2018-04-25
IL299444A (en) 2023-02-01
EP2898100B2 (en) 2023-05-10
EP3536807B1 (en) 2023-11-29
KR102307424B1 (en) 2021-09-29
WO2014043763A1 (en) 2014-03-27
AU2017251832A1 (en) 2017-11-16
CN104781422B (en) 2023-12-26
HRP20210716T1 (en) 2021-06-11
JP6985753B2 (en) 2021-12-22
HK1207124A1 (en) 2016-01-22
JP2018121644A (en) 2018-08-09
HRP20240210T1 (en) 2024-05-10
CA2884066A1 (en) 2014-03-27
IL237495A0 (en) 2015-04-30
TWI806621B (en) 2023-06-21
SG11201501927VA (en) 2015-04-29
EP2898100B9 (en) 2023-08-02
KR20230145530A (en) 2023-10-17
TW202334438A (en) 2023-09-01
EA201500327A1 (en) 2015-07-30
BR112015006183A2 (en) 2017-07-04
EP3536807A1 (en) 2019-09-11
KR102587176B1 (en) 2023-10-06
EP2898100A4 (en) 2016-05-11
KR20220065034A (en) 2022-05-19
DK3354747T3 (en) 2021-04-19
EP4056712A1 (en) 2022-09-14
JP2015536639A (en) 2015-12-24
IL237495B (en) 2019-09-26
PL2898100T5 (en) 2023-11-06
PT3354747T (en) 2021-05-07
CA3122779A1 (en) 2014-03-27
TWI707953B (en) 2020-10-21
AU2013317708B2 (en) 2017-08-03
TW201907013A (en) 2019-02-16
HUE053822T2 (en) 2021-07-28
MY173356A (en) 2020-01-21
JP6317354B2 (en) 2018-04-25
MY187444A (en) 2021-09-22
EP3354747A1 (en) 2018-08-01

Similar Documents

Publication Publication Date Title
DK3536807T3 (en) Noninvasive determination of fetal or tumor methyloma from plasma
HRP20190578T1 (en) Inhibitors of hepatitis c virus
IL258327A (en) Synthesis of antiviral compound
SMT201700094B (en) COMPOUND OF PIRAZINE CARBOSSAMIDE
DK2561103T3 (en) NON-INVASIVE DETECTION OF FETAL GENETIC ANOMALY
DK2785349T3 (en) COMBINATION TREATMENT OF CANCER
DK2717941T3 (en) Treatment of cancer
AR092198A1 (en) DERIVATIVES OF PIRAZOLOPIRIMIDINAS
CO6960555A2 (en) Preparation procedure of substituted 5-fluoro-1h-pyrazolopyridines
GB201305171D0 (en) Measurement of tissue structures
BR112014029111A2 (en) inhaler
BR112014003878A2 (en) synthesis of r-biphenylalaninol
BR112014013850A2 (en) set of shelves
FI20126266A (en) Tissue measurement
EP2800747A4 (en) Polymorphs of perampanel
HK1211919A1 (en) Synthesis of an antiviral compound
DK2802351T3 (en) Means for the treatment of triple-negative breast cancer
EP2887883A4 (en) Improved scalpel
DK2888228T3 (en) Inhibitors of CD40-TRAF6 interaction
GB201312378D0 (en) Structure of shoe
ITMI20131403A1 (en) PIECE OF VEHICLE
DK2651028T3 (en) Assessment of toothing
FR2997080B1 (en) INHIBITORS OF NEPRILYSINE
UA24071S (en) SET OF CUTLERY
ES1078391Y (en) Mountable and detachable shoes